A carregar...
Biomarkers for hepatocellular carcinoma: What’s new on the horizon?
Treatment of advanced hepatocellular carcinoma remains unsatisfying and so far only prognostic biomarkers like α-fetoprotein have been established. No clear predictive biomarker is currently available for standard of care therapies, including targeted therapies like sorafenib. Novel therapeutic opti...
Na minha lista:
| Publicado no: | World J Gastroenterol |
|---|---|
| Autor principal: | |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Baishideng Publishing Group Inc
2018
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6148424/ https://ncbi.nlm.nih.gov/pubmed/30254402 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3748/wjg.v24.i35.3974 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|